US Stock MarketDetailed Quotes
ELTP ELITE PHARMACEUTICALS INC
- 0.193
- 0.0000.00%
15min DelayClose Jul 26 16:00 ET
- 0.193
- 0.0000.00%
Post 16:01 ET
205.64MMarket Cap9.63P/E (TTM)
0.195High0.190Low387.56KVolume0.194Open0.193Pre Close74.60KTurnover0.05%Turnover Ratio9.63P/E (Static)1.07BShares0.21052wk High3.56P/B160.18MFloat Cap0.09352wk Low--Dividend TTM832.10MShs Float0.210Historical High--Div YieldTTM2.55%Amplitude0.093Historical Low0.192Avg Price1Lot Size
ELITE PHARMACEUTICALS INC Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -198.29%-3.28M | -30.61%2.06M | -321.88%-2.4M | -116.01%-239.49K | -385.42%-2.71M | -48.70%3.34M | 84.93%2.97M | -118.72%-567.88K | 872.41%1.5M | -132.50%-557.52K |
| Net income from continuing operations | 464.56%20.11M | 370.56%3.33M | -76.22%706.35K | 885.69%14.93M | 273.28%1.14M | -59.97%3.56M | -150.61%-1.23M | 30.07%2.97M | -15.68%1.52M | -87.20%305.88K |
| Operating gains losses | 1,491.46%5.78M | 380.19%700.81K | 748.38%2.42M | 458.61%2.47M | -62.14%189.37K | 70.88%-415.13K | 48.95%145.94K | 23.82%-372.89K | -64.11%-688.32K | 181.40%500.14K |
| Depreciation and amortization | 9.44%1.47M | 31.98%461.3K | 6.37%343.6K | 1.39%329.32K | -2.86%337.36K | -6.27%1.34M | -0.45%349.53K | -9.24%323.03K | -9.14%324.81K | -6.19%347.31K |
| Deferred tax | ---19.99M | ---1.93M | ---800.44K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cash items | -59,890.38%-7.52M | -340,518.68%-10.67M | 10,917.83%1.08M | --2.07M | -657.48%-3.36K | -1,187.93%-12.53K | -628.16%-3.13K | -1,612.84%-10K | --0 | 6.17%602 |
| Change In working capital | -490.40%-11.88M | -30.59%2.28M | -76.49%-6.92M | -914.45%-2.75M | -161.54%-4.49M | -99.23%-2.01M | 327.34%3.29M | -686.93%-3.92M | 118.81%337.81K | -163.46%-1.72M |
| -Change in receivables | -45,197.05%-16.6M | -242.18%-3.49M | -331.39%-5.68M | -1,497.56%-4.22M | -253.50%-3.21M | -108.36%-36.64K | 718.23%2.45M | -165.46%-1.32M | 79.57%-264.43K | -864.66%-907.2K |
| -Change in inventory | -20.30%-3.38M | 246.97%1.39M | 179.34%899.34K | -2,824.37%-4.06M | -84.67%-1.62M | -62.56%-2.81M | -1,914.56%-948.86K | -663.80%-1.13M | -5.69%148.88K | 48.18%-875.99K |
| -Change in prepaid assets | 200.07%435.4K | 170.21%394.49K | 28.36%-636.32K | 31.64%642.5K | 119.19%34.73K | -307.40%-435.12K | -74.70%146K | -35.09%-888.21K | 1,169.63%488.07K | -171.84%-180.97K |
| -Change in payables and accrued expense | 483.44%7.8M | 148.90%4.1M | -157.70%-1.51M | 19,290.10%4.9M | 3.19%309.55K | 325.37%1.34M | 139.31%1.65M | -23.93%-584.4K | 95.97%-25.52K | -59.00%299.97K |
| -Change in other current liabilities | -106.20%-139.32K | -1,768.94%-119.31K | -19.35%-7.25K | -9.55%-6.42K | 87.15%-6.33K | 70.74%-67.57K | 86.84%-6.38K | 90.19%-6.08K | 90.34%-5.86K | 17.62%-49.24K |
| -Change in other working capital | ---- | ---- | ---- | -0.03%-3.33K | 0.09%-3.33K | ---- | ---- | ---- | 0.00%-3.33K | -0.12%-3.34K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -198.29%-3.28M | -30.61%2.06M | -321.88%-2.4M | -115.78%-235.94K | -386.05%-2.71M | -48.70%3.34M | 84.93%2.97M | -118.72%-567.88K | 872.41%1.5M | -132.50%-557.52K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 85.89%-809.65K | 24.72%-403.65K | -57,003.66%-406.01K | 0 | 0 | -1,050.62%-5.74M | -102.97%-536.21K | 99.13%-711 | -3,364.35%-5.11M | -1,811.05%-94.6K |
| Net PPE purchase and sale | 85.89%-809.65K | 24.72%-403.65K | -57,003.66%-406.01K | --0 | --0 | -1,050.62%-5.74M | -102.97%-536.21K | 99.13%-711 | -3,364.35%-5.11M | -1,811.05%-94.6K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 85.89%-809.65K | 24.72%-403.65K | -57,003.66%-406.01K | --0 | --0 | -1,050.62%-5.74M | -102.97%-536.21K | 99.13%-711 | -3,364.35%-5.11M | -1,811.05%-94.6K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 98.90%3.39M | 97.11%-361.45K | 60.38%-30.65K | -107.53%-179.5K | -66.74%3.96M | 355.15%1.7M | -13,165.60%-12.5M | 49.72%-77.37K | 995.07%2.39M | 7,898.45%11.9M |
| Net issuance payments of debt | 96.17%3.34M | 96.79%-400.97K | 51.43%-37.58K | -107.53%-179.5K | -66.74%3.96M | 355.15%1.7M | -13,165.60%-12.5M | 49.72%-77.37K | 995.07%2.39M | 7,898.45%11.9M |
| Net other financing activities | --46.44K | --39.52K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 98.90%3.39M | 97.11%-361.45K | 60.38%-30.65K | -107.53%-179.5K | -66.74%3.96M | 355.15%1.7M | -13,165.60%-12.5M | 49.72%-77.37K | 995.07%2.39M | 7,898.45%11.9M |
| Net cash flow | ||||||||||
| Beginning cash position | -7.78%8.24M | -65.91%6.24M | -52.13%9.08M | -52.97%9.49M | -7.78%8.24M | 148.50%8.94M | 138.05%18.31M | 287.28%18.96M | 291.50%20.18M | 148.50%8.94M |
| Current changes in cash | -1.42%-705.59K | 112.86%1.29M | -338.49%-2.83M | 66.07%-415.44K | -88.91%1.25M | -113.02%-695.72K | -907.56%-10.07M | -123.09%-645.96K | -370.89%-1.22M | 621.74%11.24M |
| End cash Position | -8.56%7.54M | -8.56%7.54M | -65.91%6.24M | -52.13%9.08M | -52.97%9.49M | -7.78%8.24M | -7.78%8.24M | 138.05%18.31M | 287.28%18.96M | 291.50%20.18M |
| Free cash flow | -70.62%-4.09M | -31.91%1.66M | -392.76%-2.8M | 93.46%-235.94K | -315.54%-2.71M | -139.90%-2.4M | 81.37%2.43M | -119.26%-568.59K | -56,290.61%-3.61M | -138.12%-652.11K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg